Browsing by Author Francis, Prudence

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 12 of 12
Issue DateTitleAuthor(s)Citation
20121st International consensus guidelines for advanced breast cancer (ABC 1)Houssami, Nehmat; Cameron, David; Cardoso, Fatima; Costa, Anne D C; Cufer, T; Fallowfield, L. J.; Francis, Prudence; Gligorov, Joseph; Kyriakides, Stella; Lin, Nancy; Norton, Larry W; School of Public Health: Public Health1st International consensus guidelines for advanced breast cancer (ABC 1), The Breast, vol.21, 3, 2012,pp 242-252
2016Absolute benefit of adjuvant endocrine therapies for premenopausal women with hormone receptor-positive, Human epidermal growth factor receptor 2-Negative early breast cancer: TEXT and SOFT TrialsCoates, Alan; Colleoni, Marco; Fleming, Gini; Francis, Prudence; Gelber, Richard; Goldhirsch, A; Gomez, Henry; Lang, Istvan; Pagani, Olivia; Pinotti, Graziella; Price, Karen N; Regan, Meredith; Tondini, Carlo; Viale, Giuseppe; Walley, Barbara; School of Public Health: Public HealthAbsolute benefit of adjuvant endocrine therapies for premenopausal women with hormone receptor-positive, Human epidermal growth factor receptor 2-Negative early breast cancer: TEXT and SOFT Trials, Journal of Clinical Oncology, vol.34, 19, 2016,pp 2221-2230
2016Adjuvant ovarian function suppression and cognitive function in women with breast cancerBoyle, Frances; Coates, Alan; Bellet, Meritxell; Budman, Daniel; et al, .; Francis, Prudence; Karlsson, Per; Phillips, Kelly-Anne; Puglisi, Fabio; Regan, Meredith; Ribi, Karin; Spazzapan, Simon; Zaman, Khalil; Northern Clinical School: Medicine; School of Public Health: Public HealthAdjuvant ovarian function suppression and cognitive function in women with breast cancer, British Journal of Cancer, vol.114, 9, 2016,pp 956-964
2015Adjuvant ovarian suppression in premenopausal breast cancerCoates, Alan; Bellet, Meritxell; Bonnefoi, Herve; Buchholz, Stefan; Burstein, Harold; Ciruelos, Eva; Climent, Miguel; Coleman, Richard; Colleoni, Marco; Da Prada, Gian; Davidson, Nancy; Fleming, Gini; Francis, Prudence; Gelber, Richard D. (Prof); Geyer, Charles; Giobbie-Hurder, Anita; Goldhirsch, Aron (Prof); Ingle, J.; Kerbrat, Pierre; Lang, Istvan; Maibach, Rudolph; Martino, Silvana; Price, K. N; Rabaglio-Poretti, Manuela; Regan, Meredith; Ruepp, Barbara; Viale, Giuseppe; Walley, Barbara; Winer, EP; School of Public Health: Public HealthAdjuvant ovarian suppression in premenopausal breast cancer, The New England Journal of Medicine, vol.372, 5, 2015,pp 436-446
2016Adjuvant tamoxifen plus ovarian function suppression versus tamoxifen alone in premenopausal women with early breast cancer: Patient-reported outcomes in the suppression of ovarian function trialCoates, Alan; Bellet, Meritxell; Bernhard, Jurg; Burstein, Harold J.; Ciruelos, Eva; et al, Various; Francis, Prudence; Lluch, Ana; Luo, Weixiu; Pavesi, Lorenzo; Ribi, Karin; School of Public Health: Public HealthAdjuvant tamoxifen plus ovarian function suppression versus tamoxifen alone in premenopausal women with early breast cancer: Patient-reported outcomes in the suppression of ovarian function trial, Journal of Clinical Oncology, vol.34, 14, 2016,pp 1601-1610
2016Adjuvant tamoxifen plus ovarian function suppression versus tamoxifen alone in premenopausal women with early breast cancer: Patient-reported outcomes in the suppression of ovarian function trialCoates, Alan; Bellet, Meritxell; Bernhard, Jurg; Burstein, Harold J.; Ciruelos, Eva; et al, Various; Francis, Prudence; Lluch, Ana; Luo, Weixiu; Pavesi, Lorenzo; Ribi, Karin; School of Public Health: Public HealthAdjuvant tamoxifen plus ovarian function suppression versus tamoxifen alone in premenopausal women with early breast cancer: Patient-reported outcomes in the suppression of ovarian function trial, Journal of Clinical Oncology, vol.34, 14, 2016,pp 1601-1610
2013Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: Design of the TEXT and SOFT trialsCoates, Alan; Colleoni, Marco; Fleming, Gini; Francis, Prudence; Gelber, Richard; Goldhirsch, Aron (Prof); Maibach, Rudolph; Pagani, Olivia; Price, Karen; Rabaglio, Manuela; Regan, Meredith; Ruepp, Barbara; Walley, B; School of Public Health: Public HealthAdjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: Design of the TEXT and SOFT trials, The Breast, vol.22, 6, 2013,pp 1094-1100
2011Capecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast CancerCoates, Alan; Gebski, Val; Grimison, Peter; Stockler, Martin; Wilcken, Nicholas; Zannino, Diana; Ackland, Stephen; Byrne, Michael J.; Fitzharris, B; Fong, A.; Forbes, John; Francis, Prudence; Gainford, Corona; Harvey, V; Nowak, Anna; Paksec, Lisa; Simes, John; Sourjina, Tatiana; Van Hazel, Guy; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); School of Public Health: NH&MRC Clinical Trials CentreCapecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast Cancer, Journal of Clinical Oncology, vol.29, 34, 2011,pp 4498-4504
2015Goserelin for ovarian protection during breast-cancer adjuvant chemotherapyBoyle, Frances; et al, Various; Francis, Prudence; Goldstein, Lori J; Gomez, Henry; Hitre, Erike; Moore, Halle C F; Partridge, Ann H; Phillips, Kelly-Anne; Porter, David; Unger, Joseph M; Vallejos, Carlos S; Northern Clinical School: MedicineGoserelin for ovarian protection during breast-cancer adjuvant chemotherapy, New England Journal of Medicine, vol.372, 10, 2015,pp 923-932
2014Systemic treatment of HER2+ metastatic breast cancer: clinical conundrums and future perspectivesWilcken, Nicholas; Beith, Jane M.; Bell, Richard; Chirgwin, Jacquie; Chua, Sue; Colosimo, Maree; de Boer, Richard; Francis, Prudence; Green, Michael; Pittman, Kenneth; White, Michelle; Zdenkowski, Nicholas; Western Clinical School: Medicine (Westmead)Systemic treatment of HER2+ metastatic breast cancer: clinical conundrums and future perspectives, Asia-Pacific Journal of Clinical Oncology, vol.10, Suppl S4, 2014,pp 15-25
2014Systemic treatment of HER2-positive metastatic breast cancer: A systematic reviewWilcken, Nicholas; Beith, Jane; Bell, Richard; Chirgwin, Jacquie; Chua, Sue; Colosimo, Maree; de Boer, Richard; Francis, Prudence; Green, Michael; Mainwaring, Paul; Pittman, K; Snyder, Raymond; White, Michelle; Zdenkowski, Nicholas; Western Clinical School: Medicine (Westmead)Systemic treatment of HER2-positive metastatic breast cancer: A systematic review, Asia-Pacific Journal of Clinical Oncology, vol.10, S4, 2014,pp 1-14
2017Treatment efficacy, adherence, and quality of life among women younger than 35 years in the international breast cancer study group TEXT and SOFT adjuvant endocrine therapy trialsCoates, Alan; Bernhard, J; et al, Various; Francis, Prudence; Gomez, Henry; Luo, Weixiu; Pagani, Olivia; Regan, Meredith M.; Ribi, Karen; Saha, Poornima; Walley, Barbara; NH&MRC Clinical Trials CentreTreatment efficacy, adherence, and quality of life among women younger than 35 years in the international breast cancer study group TEXT and SOFT adjuvant endocrine therapy trials, Journal of Clinical Oncology, vol.35, 27, 2017,pp 3113-3122